0001528697false--08-31Q32020truefalse0.0017500000024827264248272642482726400015286972019-09-012020-05-3100015286972020-07-1500015286972020-05-3100015286972019-08-3100015286972020-03-012020-05-3100015286972019-03-012019-05-3100015286972018-09-012019-05-3100015286972018-08-3100015286972019-05-310001528697us-gaap:CommonStockMember2020-02-290001528697us-gaap:CommonStockMember2019-08-310001528697us-gaap:AdditionalPaidInCapitalMember2020-02-290001528697us-gaap:AdditionalPaidInCapitalMember2019-08-310001528697apaw:AccumulatedDeficitMember2020-02-290001528697apaw:AccumulatedDeficitMember2019-08-3100015286972020-02-290001528697us-gaap:CommonStockMember2020-03-012020-05-310001528697us-gaap:CommonStockMember2019-09-012020-05-310001528697us-gaap:AdditionalPaidInCapitalMember2020-03-012020-05-310001528697us-gaap:AdditionalPaidInCapitalMember2019-09-012020-05-310001528697apaw:AccumulatedDeficitMember2020-03-012020-05-310001528697apaw:AccumulatedDeficitMember2019-09-012020-05-310001528697us-gaap:CommonStockMember2020-05-310001528697us-gaap:AdditionalPaidInCapitalMember2020-05-310001528697apaw:AccumulatedDeficitMember2020-05-310001528697us-gaap:CommonStockMember2019-02-280001528697us-gaap:CommonStockMember2018-08-310001528697us-gaap:AdditionalPaidInCapitalMember2019-02-280001528697us-gaap:AdditionalPaidInCapitalMember2018-08-310001528697apaw:AccumulatedDeficitMember2019-02-280001528697apaw:AccumulatedDeficitMember2018-08-3100015286972019-02-280001528697us-gaap:CommonStockMember2019-03-012019-05-310001528697us-gaap:CommonStockMember2018-09-012019-05-310001528697us-gaap:AdditionalPaidInCapitalMember2019-03-012019-05-310001528697us-gaap:AdditionalPaidInCapitalMember2018-09-012019-05-310001528697apaw:AccumulatedDeficitMember2019-03-012019-05-310001528697apaw:AccumulatedDeficitMember2018-09-012019-05-310001528697us-gaap:CommonStockMember2019-05-310001528697us-gaap:AdditionalPaidInCapitalMember2019-05-310001528697apaw:AccumulatedDeficitMember2019-05-310001528697apaw:EscrowAgreementMember2017-08-012017-08-240001528697apaw:LicenseAgreementMemberapaw:SolaceManagementGroupIncMember2017-08-012017-08-24iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~February~~May 2931, 2020

~~000~~199-~~55513~~374-960

Commission File Number

~~APAWTHECARY~~Apawthecary ~~PETS~~Pets USA. (Exact name of registrant as specified in its charter)

(Exact name of registrant as specified in its charter)

Nevada		26-1679929
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

c/o Bradley Kersch 1223 Fletcher Way, Port Coquitlam, BC		V3C6B5
(Address of principal executive offices)		(Zip Code)

Nevada		26-1679929
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
c/o Brad Kersch 619 S. Ridgeley Drive, Los Angeles, CA		90036
(Address of principal executive offices)		(Zip Code)

(323) 345-4587

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required ~~tofile~~to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company~~, or an emerging growth company~~. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company,” ~~and " emerging growth company"~~ in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐ ~~Accelerated filer ☐~~ Non-accelerated filer ☒ Accelerated filer ☐ Smaller reporting company ☒ Emerging ~~growth~~Growth ~~company~~ ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☒ Yes ☐ No

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court ☐ Yes ☐ No

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of ~~April~~July 2015, 2020, we had 24,827,264 shares of common stock outstanding.

TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION			3
Item 1.	Financial Statements.	3	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	10	11
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	12	12
Item 4.	Controls and Procedures.	12	12
PART II—OTHER INFORMATION			13
Item 1.	Legal Proceedings.	13	13
Item 1A.	Risk Factors.	13	13
Item 2.	Unregistered Sales of Securities and Use of Proceeds.	13	13
Item 3.	Defaults Upon Senior Securities.	13	13
Item 4.	Mine Safety Disclosures.	13	13
Item 5.	Other Information.	13	13
Item 6.	Exhibits.	14	14

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

Apawthecary Pets USA Balance Sheets (Stated in USU.S. dollars)

	February 29,			August 31,
	May 31,2020			August 31,2019
	2020			2019
	(Unaudited)
Assets
Current assets
Cash and cash equivalents	$	~~4,405~~806		$	20,256
Total current assets		~~4,405~~806		$	20,256
Total Assets	$	~~4,405~~806		$	20,256
Liabilities and Stockholders' Deficit
Current liabilities
Accounts payable and accrued liabilities	$	13,~~855~~925		$	9,957
Accounts payable - related parties		24,~~522~~618			2,522
Due to related parties		70,673			70,673
Total current liabilities		8789,~~050~~216			83,152
Total Liabilities		8789,~~050~~216			83,152
Stockholders' deficit
Authorized
Authorized 75,000,000 of common shares, par value $0.001
75,000,000 of common shares, par value $0.001
Issued and outstanding 24,827,264 common shares issued and outstanding as of May 31, 2020 and August 31, 2019		24,827			24,827
Issued and outstanding
Additional paid-in capital		349,223			349,223
24,827,264 common shares issued and outstanding
Accumulated deficit		(462,460	)		(436,946	)
as of February 29, 2020 and August 31, 2019		24,827			24,827
Total stockholders' deficit		(88,410	)		(62,896	)
Additional paid in capital		349,223			349,223
Total Liabilities and Stockholders' Deficit	$	806		$	20,256
Accumulated deficit		(456,695	)		(436,946	)
Total stockholders' deficit	$	(82,645	)	$	(62,896	)
Total Liabilities and Stockholders' Deficit	$	4,405		$	20,256

The accompanying notes are an integral part of the these unaudited financial statements.

3 Table of ~~Content~~Contents

Apawthecary Pets USA ~~Statements of Operations (Stated in U.S. Dollars)~~

	For the			For the			For the			For the
	three months			three months			six months			six months
	ended			ended			ended			ended
	February 29,			February 28,			February 29,			February 28,
	2020			2019			2020			2019
	(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)
Operating Expenses
General and administrative	$	14,197		$	13,866		$	19,749		$	18,988
Total operating Expenses		14,197			13,866			19,749			18,988
Net loss	$	(14,197	)	$	(13,866	)	$	(19,749	)	$	(18,988	)
Basic and diluted net loss per common share - basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Weighted average number of common shares - basic and diluted		24,827,264			24,827,264			24,827,264			24,827,264

Statements of Operations

(Stated in U.S. Dollars)

	For the			For the			For the			For the
	Three Months			Three Months			Nine Months			Nine Months
	Ended			Ended			Ended			Ended
	May 31,			May 31,			May 31,			May 31,
	2020			2019			2020			2019
	(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)
Operating Expenses
General and administrative	$	5,765		$	4,762		$	25,514		$	23,750

Total operating Expenses		5,765			4,762			25,514			23,750

Net loss	$	(5,765	)	$	(4,762	)	$	(25,514	)	$	(23,750	)

Basic and diluted net loss per common share - basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Weighted average number of common shares - basic and diluted		24,827,264			24,827,264			24,827,264			24,827,264

The accompanying notes are an integral part of the these unaudited financial statements.

4 Table of ~~Content~~Contents

Apawthecary Pets USA Statements of Cash Flows (Stated in USU.S. dollars)

	For the			For the
	six months			six months
	Nine months			Nine months
	ended			ended
	Ended			Ended
	February 29,			February 28,
	May 31,			May 31,
	2020			2019
	(Unaudited)			(Unaudited)
Cash flows from operating activities
Net loss	$	(1925,~~749~~514	)	$	(1823,~~988~~750	)
Adjustments to reconcile net loss to net cash used in operating activities:
Accounts payable and accrued liabilities		3,~~898~~968			6,~~339~~709
Cash flows used in operating activities		(15,851	)		(12,649	)
Accounts payable - related parties		2,096			-
Net decrease in cash and cash equivalents		(15,851	)		(12,649	)
Cash flows used in operating activities		(19,450	)		(17,041	)
Net decrease in cash and cash equivalents		(19,450	)		(17,041	)
Cash and cash equivalents, beginning of period		20,256			42,594
Cash and cash equivalents, end of period	$	~~4,405~~806		$	2925,~~945~~553
Supplemental disclosures of cash flow information:
Interest paid	$	-		$	-
Income tax paid	$	-		$	-

The accompanying notes are an integral part of the these unaudited financial statements.

5 Table of ~~Content~~Contents

Apawthecary Pets USA Statements of Changes in Stockholders' Deficit (Stated in U.S. Dollars) For the ~~three~~Three ~~months~~Months ~~ended~~Ended ~~February~~May 2931, 2020 and ~~February~~May 2831, 2019 (Unaudited)

	Common stock				Additional		Accumulated
	Shares		Amount		paid-in capital		Deficit			Total
Balance at November 30, 2019		24,827,264	$	24,827	$	349,223	$	(442,498	)	$	(68,448	)
Net loss		-		-		-		(14,197	)		(14,197	)
Balance at February 29, 2020		24,827,264	$	24,827	$	349,223	$	(456,695	)	$	(82,645	)
Balance at November 30, 2018		24,827,264	$	24,827	$	349,223	$	(405,671	)	$	(31,621	)
Net loss		-		-		-		(5,765	)		(5,765	)
Net loss		-		-		-		(13,866	)		(13,866	)
Balance at May 31, 2020		24,827,264	$	24,827	$	349,223	$	(462,460	)	$	(88,410	)
Balance at February 28, 2019		24,827,264	$	24,827	$	349,223	$	(419,537	)	$	(45,487	)
Net loss		-		-		-		(4,762	)		(4,762	)
Balance at May 31, 2019		24,827,264	$	24,827	$	349,223	$	(424,299	)	$	(50,249	)

The accompanying notes are an integral part of the these unaudited financial statements.

6 Table of ~~Content~~Contents

Apawthecary Pets USA Statements of Changes in Stockholders' Deficit (Stated in U.S. Dollars) For the ~~six~~Nine ~~months~~Months ~~ended~~Ended ~~February~~May 2931, 2020 and ~~February~~May 2831, 2019 (Unaudited)

	Common stock				Additional		Accumulated
	Shares		Amount		paid-in capital		Deficit			Total
Balance at August 31, 2019		24,827,264	$	24,827	$	349,223	$	(436,946	)	$	(62,896	)
Net loss		-		-		-		(1925,~~749~~514	)		(1925,~~749~~514	)
Balance at February 29, 2020		24,827,264	$	24,827	$	349,223	$	(456,695	)	$	(82,645	)
Balance at May 31, 2020		24,827,264	$	24,827	$	349,223	$	(462,460	)	$	(88,410	)
Balance at August 31, 2018		24,827,264	$	24,827	$	349,223	$	(400,549	)	$	(26,499	)
Net loss		-		-		-		(1823,~~988~~750	)		(1823,~~988~~750	)
Balance at February 28, 2019		24,827,264	$	24,827	$	349,223	$	(419,537	)	$	(45,487	)
Balance at May 31, 2019		24,827,264	$	24,827	$	349,223	$	(424,299	)	$	(50,249	)

The accompanying notes are an integral part of the these unaudited financial statements.

7 Table of ~~Content~~Contents

Apawthecary Pets USA Notes to Financial Statements (Stated in U.S. Dollars) (Unaudited)

1. Nature and Continuance of Operations

Apawthecary Pets USA (the “Company”) was incorporated under the laws of the States of Nevada on December 27, 2007. The Company intends to operate in the pet industry.

On July 20, 2017, the Company changed its name from Bookedbyus Inc. to Apawthecary Pets USA.

The Company’s financial statements as at ~~February~~May 2931, 2020 and for the period then ended have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company has a loss of $1925,~~749~~514 for the ~~six~~nine months ended ~~February~~May 2931, 2020 and has a working capital deficit at ~~February~~May 2931, 2020. These factors raise substantial doubt about the ability of the Company to continue as a going concern. .

Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. Management believes that the Company’s capital resources should be adequate to continue operating and maintaining its business strategy for the twelve months after the date the financial statements are issued. However, if the Company is unable to raise additional capital in the near future, due to the Company’s liquidity problems, management expects that the Company will need to curtail operations, liquidate assets, seek additional capital on less favorable terms and/or pursue other remedial measures. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

As of ~~February~~May 2931, 2020, the Company was not engaged in continued business, and had significant expenses from early stage activities. Although management is currently attempting to implement its business plan and is seeking additional sources of financing, there is no assurance the activity will be successful. Accordingly, the Company must rely on its president to perform essential functions without compensation until a business operation can be commenced. The financial statements do not include any adjustments that may result from the outcome of this uncertainty.

2. Significant Account Policies

Basis of presentation

The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the Company’s audited financial statement for the year ended August 31, 2019, as filed with the SEC on Form 10-K. In the opinion of management, all normal recurring adjustments which are necessary for a fair presentation of financial statements of the results for the interim period ended ~~February~~May 2931, 2020, have been included.

The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal year ended August 31, 2019, as reported in the Form 10-K have been omitted.

8 Table of ~~Content~~Contents

Apawthecary Pets USA Notes to Financial Statements (Stated in U.S. Dollars) (Unaudited)

3. Due to Related Parties and Related Party Transactions

The outstanding balance of management fees payable is $24,~~522~~618 and $2,522 as of ~~February~~May 2931, 2020 and August 31, 2019 respectively.

As of ~~February~~May 2931, 2020, related parties of the Company have provided a series of loans, totaling $70,673 (August 31, 2019 - $70,673) for working capital purposes. These loans are unsecured, interest-free, and due on demand.

On August 24, 2017 Apawthecary Pets USA entered into a license agreement with Solace Management Group Inc. a British Columbia corporation. The material terms of such license agreement are:

1. Upon execution of the Agreement, the Apawthecary Pets USA shall provide a non-refundable license fee in the amount of $100,000 (the "License Fee") to be held in an escrow account pursuant and subject to the terms of an escrow agreement whereby the License Fee will remain in the escrow account until the earlier of a $3,000,000 raise by the Licensee or after the Set-up Period. 2. Term of the License Agreement is 10 years with a 5 years renewal term. 3. The license is an exclusive, non-transferable, non-sub licensable license to manufacture, sell, represent, market, distribute and advertise the Licensed Products within the Territory on the terms and conditions set forth in the License Agreement and shall include access to, and use of, the Solace Products within the Territory on the terms and conditions set forth in the License Agreement and shall include access to, and use of, the Solace Management Group Inc.’s Licensed Products and Services, Marks, Manuals, brands, and the business format, formulations, methods, specifications, standards, and operating procedures. 4. Apawthecary Pets USA shall pay the Solace Management Group Inc. for all packaging and shipment expenses to the Licensee at the then current market rate plus 20%. 5. Royalties will commence to accrue when the Licensed Products are accepted by the Apawthecary Pets USA. Apawthecary Pets USA shall pay quarterly royalties in addition to the yearly royalty fee, 10% of sales based on the wholesale price of each item.

2. Term of the License Agreement is 10 years with a 5 year renewal term.

3. The license is an exclusive, non-transferable, non-sub licensable license to manufacture, sell, represent, market, distribute and advertise the Licensed Products within the Territory on the terms and conditions set forth in the License Agreement and shall include access to, and use of, the Solace Products within the Territory on the terms and conditions set forth in the License Agreement and shall include access to, and use of, the SolaceManagement Group Inc.’s Licensed Products and Services, Marks, Manuals, brands, and the business format, formulations, methods, specifications,standards, and operating procedures.

4. Apawthecary Pets USA shall pay the Solace Management Group Inc. for all packaging and shipment expenses to the Licensee at the then current market rate plus 20%.

5. Royalties will commence to accrue when the Licensed Products are accepted by the Apawthecary Pets USA. Apawthecary Pets USA shall pay quarterly royalties in addition to the yearly royalty fee, 10% of sales based on the wholesale price of each item.

9 Table of Content

Apawthecary Pets USA Notes to Financial Statements (Stated in U.S. Dollars) (Unaudited)

Solace Management Group Inc. owns the brand and intellectual property rights to Apawthecary Pets.

Apawthecary Pets Inc., a Canadian corporation licensed the brand and distribution rights for Apawthecary Pets for use in Canada from Solace Management Group Inc.

Solace Management Group Inc. and Apawthecary Pets USA have an officer and director in common, Bradley Kersch. Apawthecary Pets USA has negotiated a licensing and distribution agreement with Solace Management Group Inc. The $100,000 License fee has not been paid as of ~~February~~May 2931, 2020.

Aerock Fox provides consulting service to the Company without compensation.

Digital Pilot Inc., a company that has a common director (Aerock Fox) with Apawthecary Pets USA, provides an office located in 619 S. Ridgley, Los Angeles CA for an indefinite period of time. with no charge.

109 Table of ~~Content~~Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Management’s Discussion and Analysis

This section of the Form 10-Q includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like believe, expect, estimate, anticipate, intend, project and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our predictions.

Apawthecary Pets USA (formerly Bookedbyus Inc.) (the “Company”) was incorporated under the laws of the State of Nevada on December 27, 2007. The Company intends to operate in the pet industry. We have commenced only limited operations, primarily focused on organizational matters to the date of this filling. The Company has not yet implemented its business model.

Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. However, if the Company is unable to raise additional capital in the near future, due to the Company’s liquidity problems, management expects that the Company will need to curtail operations, liquidate assets, seek additional capital on less favorable terms and/or pursue other remedial measures. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

On August 24, 2017, Apawthecary Pets USA entered into a license agreement with Solace Management Group Inc. a British Columbia corporation. The material terms of such license agreement are:

1. Upon execution of the Agreement, the Apawthecary Pets USA shall provide a non-refundable license fee in the amount of $100,000 (the ~~"LicenseFee"~~“License Fee”) to be held in an escrow account pursuant and subject to the terms of an escrow agreement whereby the License Fee will remain in the escrow account until the earlier of a $3,000,000 raise by the Licensee or after the Set-up Period. 2. Term of the License Agreement is 10 years with a 5 year renewal term. 3. The license is an exclusive, non-transferable, non-sub licensable license to manufacture, sell, represent, market, distribute and advertise the Licensed Products within the Territory on the terms and conditions set forth in the License Agreement and shall include access to, and use of, the Solace Management Group Inc.’s Licensed Products and Services, Marks, Manuals, brands, and the business format, formulations, methods, specifications, standards, and operating procedures. 4. Apawthecary Pets USA shall pay the Solace Management Group Inc. for all packaging and shipment expenses to the Licensee at the then current market rate plus 20%. 5. Royalties will commence to accrue when the Licensed Products are accepted by the Apawthecary Pets USA. Apawthecary Pets USA shall pay quarterly royalties in addition to the yearly royalty fee, 10% of sales based on the wholesale price of each item.

Solace Management Group Inc. owns the brand and intellectual property rights to Apawthecary Pets.

Apawthecary Pets Inc., a Canadian corporation licensed the brand and distribution rights for Apawthecary Pets for use in Canada from Solace Management Group Inc.

Solace Management Group Inc. and Apawthecary Pets USA have an officer and director in common, Bradley Kersch. Apawthecary Pets USA has ~~negotiateda~~negotiated a licensing and distribution agreement with Solace Management Group Inc. The $100,000 License fee has not been paid as of ~~February~~May 2931, 2020.

In March 2020, the WHO declared the outbreak of COVID-19 as a pandemic based on the rapid increase in global exposure. COVID-19 continues to spread throughout the world, including the United States. We have not seen any significant direct negative impact of COVID-19 to the Company. However, given the daily evolution of the COVID-19 pandemic and the global responses to curb its spread, we are not presently able to estimate the effects of the COVID-19 pandemic on our future results of operations, financial condition, or liquidity for the remainder of fiscal year 2020 and, possibly, beyond.

Table of Contents

Capital Resources and Liquidity

Our auditors have issued a “going concern” opinion, meaning that there is substantial doubt if we can continue as an on-going business unless we obtain additional capital. No substantial revenues from our planned business model are anticipated until we have raised sufficient monies to implement our business model. The Company will need to seek capital from other resources such as private placements in the Company’s common stock or debt financing, which may not even be available to the Company. However, if such financing were available, because we are a development stage company with no or limited operations to date, it would likely have to pay additional costs associated with such financing and in the case of high risk loans be subject to an above market interest rate. At such time these funds are required, management would evaluate the terms of such financing. If the company cannot raise additional proceeds via such financing, it would be required to cease business operations.

11As ~~Table~~of May 31, 2020, we had $806 in cash as compared to $20,256 as at August 31, 2019. As of ~~Content~~the date of this Form 10-Q, the current funds available to the Company will not be sufficient to fund the expenses related to the implementation of our business and continue maintaining a reporting status. The Company’s sole officer and director, Mr. Kersch has indicated that he may be willing to provide a maximum of $20,000, required to maintain the reporting status, in the form of a non-secured loan for the next twelve months as the expenses are incurred if no other proceeds are obtained by the Company. However, there is no contract or written agreement in place.

The Company will need to seek capital from other resources such as private placements or in the Company’s sales of registered securities, or debt financing, which may not even be available to the Company. However, if such financing were available, because we are a development stage company with no or limited operations to date, it would likely have to pay additional costs associated with such financing and in the case of high risk loans be subject to an above market interest rate. At such time these funds are required, management would evaluate the terms of such financing. If the company cannot raise additional proceeds via such financing, it would be required to cease business operations.

As of February 29, 2020, we had $4,405 in cash as compared to $20,256 as at August 31, 2019. As of the date of this Form 10-Q, management believes that the Company’s capital resources should be adequate to continue operating and maintaining its business strategy twelve months after the date that the financial statements are issued. However, if the Company is unable to raise additional capital in the near future, due to the Company’s liquidity problems, management expects that the Company will need to curtail operations, liquidate assets, seek additional capital on less favorable terms and/or pursue other remedial measures.

We do not anticipate researching any further products nor the purchase or sale of any significant equipment. We also do not expect any significant additions to the number of employees.

Results of Operations

We had $nil in revenue for the three and nine month period ended ~~February~~May 2931, 2020 as compared to revenue ~~of $nil~~ for three ~~month~~and ~~period~~nine ~~ended February 28, 2019. We had $nil in revenue for the six~~ month period ended ~~February~~May 2931, ~~2020,~~2019 ~~as compared to revenue~~ of $nil ~~for six month period ended February 28, 2019~~.

Total operating expenses infor the three month period ended ~~February~~May 2931, 2020 were $145,~~197~~765 as compared to total operating expenses ~~of $13,866~~ for the three month period ended ~~February~~May 2831, 2019 of 4,762 resulting in a net loss ~~of $14,197~~ for the three month period ended ~~February~~May 2931, 2020 of $5,765 as compared to a net loss of $134,~~866~~762 for ~~the~~ three ~~months~~month period ended ~~February~~May 2831, 2019. The net loss for the three month period ended ~~February~~May 2931, 2020 is a result of general and administrative expense of $145,~~197~~765 as compared to the net loss ~~of $13,866~~ for the three month period ended ~~February~~May 2831, 2019 of $4,762 which was a result of general and administrative expense of $134,~~866~~762.

Total operating expenses infor the ~~six~~nine month period ended ~~February~~May 2931, 2020 were $1925,~~749~~514 as compared to total operating expenses ~~of $18,988~~ for the ~~six~~ nine month period ended ~~February~~May 2831, 2019 of $23,750 resulting in a net loss ~~of $19,749~~ for the ~~six~~nine month period ended ~~February~~May 2931, 2020 of $25,514 as compared to a net loss of $1823,~~988~~750 for ~~the~~nine ~~six~~month ~~months~~period ended ~~February~~May 2831, 2019. The net loss for the ~~six~~nine month period ended ~~February~~May 2931, 2020 is a result of general and administrative expense of $1925,~~749~~514 as compared to the net loss ~~of $18,988~~ for the ~~six~~nine month period ended ~~February~~May 2831, 2019 of $23,750 which was a result of general and administrative expense of $1823,~~988~~750.

Off-balance sheet arrangements

The Company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect or change on the company’s financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with the company is a party, under which the company has (i) any obligation arising under a guarantee contract, derivative instrument or variable interest; or (ii) a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is accumulated and communicated to management including our principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

12In ~~Table~~connection with this quarterly report, as required by Rule 15d-15 under the Securities Exchange Act of ~~Content~~1934, we have carried out an evaluation of the effectiveness of the design and operation of our company's disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our company's management, including our company's principal executive officer and principal financial officer. Based upon that evaluation, our company's principal executive officer and principal financial officer concluded that as of May 31, 2020 our disclosure controls and procedures were not effective due to the existence of material weaknesses in our internal controls over financial reporting.

In connection with this quarterly report, as required by Rule 15d-15 under the Securities Exchange Act of 1934, we have carried out an evaluation of the effectiveness of the design and operation of our company's disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our company's management, including our company's principal executive officer and principal financial officer. Based upon that evaluation, our company's principal executive officer and principal financial officer concluded that subject to the inherent limitations noted in this Part II, Item 9A(T) as of February 29, 2020, our disclosure controls and procedures were not effective due to the existence of material weaknesses in our internal controls over financial reporting.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f)) during the quarter ended ~~February~~May 2931, 2020 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

Currently we are not involved in any pending litigation or legal proceeding.

Item 1A. Risk Factors.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 2. Unregistered Sales of Securities and Use of Proceeds.

None

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosure.

None

Item 5. Other Information.

(a) None

13 Table of ~~Content~~Contents

Item 6. Exhibits.

The following documents are filed as a part of this report or are incorporated by reference to previous filings, if so indicated:

Exhibit No.		Description
3.1		Certificate of Amendment as previously filed with the SEC on Form S-1 on September 15, 2017
3.2		By-Laws Inc. as previously filed with the SEC on Form S-1 on September 7, 2011
31.1		Certification of Chief Executive Officer Pursuant to Rule 13a–14(a) or 15d-14(a) of the Securities Exchange Act of 1934
31.2		Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934*
32.1		Certification of Chief Executive Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification of Chief Financial Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101		Interactive data files pursuant to Rule 405 of Regulation S-T.

_________

101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH		Inline XBRL Taxonomy Extension Schema Document.

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

__________

* Included in Exhibit 31.1

** Included in Exhibit 32.1

14 Table of ~~Content~~Contents

SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Apawthecary Pets USA
	Apawthecary Pets USA.
Date: April 20, 2020	By:	/s/ Brad Kersch
July 15, 2020	By:	/s/ Bradley Kersch
		Brad Kersch
		Bradley Kersch
		President and Director Principal Executive Officer Principal Financial Officer
		President, Chief Executive Officer (Principal Executive Officer) and Director

Filing Compare · Apawthecary Pets USA